Rain Therapeutics Stock Profit Margin
RAINDelisted Stock | USD 1.41 0.01 0.70% |
Rain Therapeutics fundamentals help investors to digest information that contributes to Rain Therapeutics' financial success or failures. It also enables traders to predict the movement of Rain Stock. The fundamental analysis module provides a way to measure Rain Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Rain Therapeutics stock.
Rain |
Rain Therapeutics Company Profit Margin Analysis
Rain Therapeutics' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, Rain Therapeutics has a Profit Margin of 0.0%. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The profit margin for all United States stocks is 100.0% lower than that of the firm.
Did you try this?
Run Pattern Recognition Now
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges |
All Next | Launch Module |
Rain Fundamentals
Return On Equity | -0.97 | |||
Return On Asset | -0.52 | |||
Current Valuation | (32.85 M) | |||
Shares Outstanding | 27.58 M | |||
Shares Owned By Insiders | 16.48 % | |||
Shares Owned By Institutions | 68.38 % | |||
Number Of Shares Shorted | 661.11 K | |||
Price To Book | 0.65 X | |||
EBITDA | (73.56 M) | |||
Net Income | (72.26 M) | |||
Cash And Equivalents | 90.73 M | |||
Cash Per Share | 3.41 X | |||
Total Debt | 277 K | |||
Debt To Equity | 0 % | |||
Current Ratio | 7.20 X | |||
Book Value Per Share | 1.86 X | |||
Cash Flow From Operations | (65.76 M) | |||
Short Ratio | 1.90 X | |||
Earnings Per Share | (2.07) X | |||
Target Price | 1.58 | |||
Number Of Employees | 63 | |||
Beta | 0.27 | |||
Market Capitalization | 44.01 M | |||
Total Asset | 135.18 M | |||
Retained Earnings | (165.69 M) | |||
Working Capital | 111.66 M | |||
Z Score | 92.82 | |||
Net Asset | 135.18 M |
About Rain Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Rain Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rain Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rain Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Rain Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Rain Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rain Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Rain Stock
0.65 | PPERY | Bank Mandiri Persero | PairCorr |
0.62 | PPERF | Bank Mandiri Persero | PairCorr |
0.7 | BKRKY | Bank Rakyat | PairCorr |
Moving against Rain Stock
0.81 | CSCO | Cisco Systems | PairCorr |
0.77 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
0.66 | T | ATT Inc Fiscal Year End 22nd of January 2025 | PairCorr |
0.62 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
0.6 | DIS | Walt Disney | PairCorr |
The ability to find closely correlated positions to Rain Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Rain Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Rain Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Rain Therapeutics to buy it.
The correlation of Rain Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Rain Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Rain Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Rain Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Rain Stock
If you are still planning to invest in Rain Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rain Therapeutics' history and understand the potential risks before investing.
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |